- Filed
- Feb 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 21, 2025 | 38.18M sh |
| Cash And Equivalents restated | FY 2024 · Dec 31, 2023 | $43M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $114.83M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $130.05M |
| Current Assets | FY 2024 · Dec 31, 2023 | $146.34M |
| Total Assets | FY 2024 · Dec 31, 2023 | $289.19M |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 40.14M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $5.72M |
| Capex | FY 2024 · Dec 31, 2022 | $5M |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2022 | −$5.76M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$0.36 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$0.36 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $55.55M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $41.74M |
| Net Income | FY 2024 · Dec 31, 2022 | −$14.43M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$27.12M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $148.57M |
| Revenue | FY 2024 · Dec 31, 2022 | $219.01M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $219.78M |